| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 386 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 342 |
| 2 | TACROLIMUS OINTMENT 0.1% | 342 |
| 3 | MYCOPHENOLATE MOFETIL | 270 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 270 |
| 5 | PREDNISONE | 148 |
| 6 | PREDNISOLONE | 109 |
| 7 | PREDNISOLONE ORAL | 109 |
| 8 | PREDNISOLONE ORAL SOLUTION | 109 |
| 9 | CYCLOPHOSPHAMIDE | 92 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 1 | PENTOSTATIN | 16 | 0.0152 |
| 2 | CIDOFOVIR ANHYDROUS | 20 | 0.0138 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 62 | 0.0074 |
| 4 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 7 | 0.0068 |
| 5 | MEFLOQUINE HYDROCHLORIDE | 1 | 0.0064 |
| 6 | DUVELISIB | 5 | 0.0059 |
| 7 | FOSCARNET SODIUM | 20 | 0.0050 |
| 8 | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | 1 | 0.0048 |
| 9 | BASILIXIMAB | 57 | 0.0048 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 7 | 0.0032 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 39 | 0.0017 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 37 | 0.0017 |
| 3 | Non-narcotic Antitussive [EPC] | 27 | 0.0016 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 5 | 0.0011 |
| 5 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 6 | Glycopeptide Antibacterial [EPC] | 60 | 0.0009 |
| 7 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 2 | 0.0008 |
| 8 | Glinide [EPC] | 7 | 0.0008 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 71 | 0.0007 |